Clinical Trial Update: A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People [Phase 1]

View source ↗

Summary

A Phase 1 safety study of the investigational drug NNC0705-0001 in healthy volunteers and individuals with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• NNC0705-0001

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Chronic Kidney Disease | Phase 1 | Status: COMPLETED